Filtros de búsqueda

Lista de obras de Lynne Mofenson

'There are no more secrets': acceptability of a family-centered model of care for HIV positive children in Eswatini

scientific article published on 15 October 2020

24-month HIV-free survival among infants born to HIV-positive women enrolled in Option B+ program in Kigali, Rwanda: The Kabeho Study

artículo científico publicado en 2017

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

article

A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance

artículo científico publicado en 2014

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

artículo científico publicado en 1999

A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini

artículo científico publicado en 2021

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection

article

A trial of three antiretroviral regimens in HIV-1-infected children

artículo científico publicado en 2004

A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers

artículo científico publicado en 2012

ANTIRETROVIRAL THERAPY AND INTERRUPTION OF HIV PERINATAL TRANSMISSION

article

Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative review

artículo científico publicado en 2020

Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities

artículo científico publicado en 2018

Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero

artículo científico publicado en 2010

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis

artículo científico publicado en 2012

Advances in the prevention of vertical transmission of human immunodeficiency virus

artículo científico publicado en 2003

Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women

artículo científico publicado en 2021

Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings

artículo científico publicado en 2003

Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy

scientific article published on 09 October 2019

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis

artículo científico publicado en 2011

Antibody maturation and viral diversification in HIV-infected women

artículo científico publicado en 2013

Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy

artículo científico publicado en 2004

Antiretroviral Prophylaxis to Reduce Breast Milk Transmission of HIV Type 1: New Data but Still Questions

artículo científico publicado en 2008

Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?

artículo científico publicado en 2015

Antiretroviral Treatment of HIV/AIDS During Pregnancy

artículo científico publicado en 2023

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children

artículo científico publicado en 2011

Antiretroviral drugs to prevent breastfeeding HIV transmission

artículo científico publicado en 2010

Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance

artículo científico publicado en 2002

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

artículo científico publicado en 2002

Antiretroviral treatment for children with peripartum nevirapine exposure

artículo científico publicado en 2010

Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.

artículo científico publicado en 2011

Antiretrovirals in pregnancy: a note of caution

artículo científico publicado en 2012

Assessing Very Early Infant Diagnosis Turnaround Times: Findings from a Birth Testing Pilot in Lesotho.

artículo científico publicado en 2017

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries

artículo científico publicado en 2022

Association of Antiretroviral Drug Regimen With Viral Suppression in HIV-positive Children on Antiretroviral Therapy in Eswatini

artículo científico publicado en 2019

Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component

artículo científico publicado en 2021

Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission

artículo científico publicado en 2006

Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.

artículo científico publicado en 1996

Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection

artículo científico publicado en 2005

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents

artículo científico publicado en 2011

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

artículo científico publicado en 2007

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

artículo científico publicado en 2016

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

article

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication

artículo científico publicado en 2010

Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057.

artículo científico publicado en 2016

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

artículo científico publicado en 2005

Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection

artículo científico publicado en 2016

Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium

artículo científico publicado en 2017

COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss

artículo científico publicado en 2024

Can Perinatal HIV Infection Be Eliminated in the United States?

artículo científico publicado en 1999

Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers

artículo científico publicado en 2015

Challenges in the Early Infant HIV Diagnosis and Treatment Cascade

artículo científico publicado en 2020

Challenges in the Elimination of Pediatric HIV-1 Infection

artículo científico publicado en 2016

Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group

artículo científico publicado en 1998

Characterizing and Managing Pediatric SARS-CoV-2 Infection. Learning about the Virus in a Global Classroom

artículo científico publicado en 2020

Children born into families affected by HIV.

artículo científico publicado en 2014

Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission

artículo científico publicado en 2015

Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes

artículo científico publicado en 2016

Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo

scientific article published on 02 October 2020

Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

artículo científico publicado en 2022

Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol

scientific article published on 02 December 2020

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

artículo científico publicado en 2020

Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants

artículo científico publicado en 2007

Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study

artículo científico publicado en 2013

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

artículo científico publicado en 2002

Combination antiretroviral use and preterm birth

artículo científico publicado en 2012

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

artículo científico publicado en 1999

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission

artículo científico publicado en 2018

Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis

artículo científico publicado en 2020

Concentrations of protease inhibitors in cord blood after in utero exposure

artículo científico publicado en 2002

Congenital CMV and HIV Perinatal Transmission.

artículo científico publicado en 2018

Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks?

artículo científico publicado en 2017

Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step

artículo científico publicado en 2006

Creating Sustainable Collaborations for Implementation Science: The Case of the NIH-PEPFAR PMTCT Implementation Science Alliance

artículo científico publicado en 2016

Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Hum

artículo científico publicado en 1994

Crucial need for improved pharmacovigilance in pregnancy

artículo científico publicado en 2023

Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection

artículo científico publicado en 2017

Decision Making in a Time of Uncertainty: Dolutegravir for Reproductive-Age Women

scientific article published on 02 April 2019

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era

artículo científico publicado en 2010

Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework

scientific article published on 01 August 2020

Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics

artículo científico publicado en 1998

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot

artículo científico publicado en 2002

Diagnosis of HIV Infection During Early Infancy: How Early Is Early Enough?

artículo científico publicado en 2016

Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants

artículo científico publicado en 2016

Early antiretroviral therapy of HIV-infected infants in resource-limited countries: possible, feasible, effective and challenging

artículo científico publicado en 2008

Early neurodevelopmental markers predictive of mortality in infants infected with HIV-1.

artículo científico publicado en 2003

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial

artículo científico publicado en 2012

Editorial commentary: New challenges in the elimination of pediatric HIV infection: the expanding population of HIV-exposed but uninfected children

artículo científico publicado en 2015

Efavirenz reclassified as FDA pregnancy category D.

artículo científico publicado en 2005

Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study

article

Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration

artículo científico publicado en 2020

Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.

artículo científico publicado en 2003

Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial

artículo científico publicado en 1993

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis

artículo científico publicado en 2024

Effects of Polymorphisms of Chemokine Receptors on Neurodevelopment and the Onset of Encephalopathy in Children with Perinatal HIV-1 Infection

article

Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi

artículo científico publicado en 2011

Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial

artículo científico publicado en 2024

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2011

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2014

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

artículo científico publicado en 1999

Elevated CD8+DR+ lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group

artículo científico publicado en 1997

Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?

scientific article published on 01 January 2020

Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project

artículo científico publicado en 2021

Enhanced and timely investigation of ARVs for use in pregnant women

scientific article published on 08 December 2020

Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models

artículo científico publicado en 2012

Estimating the cost of diagnosing HIV at birth in Lesotho

scientific article published in PLoS ONE

Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial

artículo científico publicado en 2021

Evaluation and management of the infant exposed to HIV-1 in the United States

artículo científico publicado en 2009

Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team

artículo científico publicado en 1997

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

artículo científico publicado en 2012

Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2012

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission

artículo científico publicado en 2008

Faculty of 1000 evaluation for Changing Trends in Complications and Mortality among US Youth and Young Adults with HIV Infection in the Era of Combination Antiretroviral Therapy

article

Faculty of 1000 evaluation for Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-Infected Infants in a Resource-Limited Country: The ANRS-Pediacam Study in Cameroon

article

Faculty of 1000 evaluation for Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

Faculty of 1000 evaluation for Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life

article

Faculty of 1000 evaluation for Maternal immunization

Faculty of 1000 evaluation for Missed Opportunities for Early Infant HIV Diagnosis: Results of a National Study in South Africa

article

Faculty of 1000 evaluation for Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012

article

Faculty of 1000 evaluation for Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia

article

Faculty of 1000 evaluation for Pubertal development in HIV-infected African children on first-line antiretroviral therapy

article

Faculty of 1000 evaluation for Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country

article

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

artículo científico publicado en 2011

Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi

artículo científico publicado en 2010

GB virus C infection in children with perinatal human immunodeficiency virus infection

artículo científico publicado en 2005

Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection

artículo científico publicado en 2010

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

artículo científico publicado en 2022

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy

artículo científico publicado en 2002

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

artículo científico publicado en 2009

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the

artículo científico publicado en 2013

HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study

artículo científico publicado en 2017

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission

artículo científico publicado en 2014

Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol

artículo científico publicado en 2004

Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. For the Women and Infants Transmission Study

artículo científico publicado en 2000

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

artículo científico publicado en 2001

Human immunodeficiency virus, mycobacterium tuberculosis, and pregnancy: a deadly combination

artículo científico publicado en 2007

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

artículo científico publicado en 2000

Immune Reconstitution after Receipt of Highly Active Antiretroviral Therapy in Children with Advanced or Progressive HIV Disease and Complete or Partial Viral Load Responsea

article

Immune parameters and morbidity in hard drug and human immunodeficiency virus-exposed but uninfected infants

artículo científico publicado en 2004

Immunologic targets of HIV infection: T cells. NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group.

artículo científico publicado en 1993

Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort

artículo científico publicado en 2007

Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants

artículo científico publicado en 2013

Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial

artículo científico publicado en 2021

Improving estimates of children living with HIV from the Spectrum AIDS Impact Model

artículo científico publicado en 2017

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children

artículo científico publicado en 2007

In-utero ART exposure and the need for pharmacovigilance

artículo científico publicado en 2018

Infant outcomes after maternal antiretroviral exposure in resource-limited settings

artículo científico publicado en 2012

Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.

artículo científico publicado en 2018

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants

artículo científico publicado en 2011

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update

artículo científico publicado en 2007

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

article

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

artículo científico publicado en 2003

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

artículo científico publicado en 1999

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

artículo científico publicado en 1999

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine

artículo científico publicado en 1999

Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children

artículo científico publicado en 2004

Long-acting antiretrovirals and HIV treatment adherence

artículo científico publicado en 2023

Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A

artículo científico publicado en 2015

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

artículo científico publicado en 2015

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

article

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.

artículo científico publicado en 2016

Male circumcision for prevention of HIV and other sexually transmitted diseases

artículo científico publicado en 2007

Manipulating the immune system with immune globulin. The National Institute of Child Health and Human Development. Intravenous Immunoglobulin Study Group

artículo científico publicado en 1992

Maternal Drug Use in Perinatal HIV Studies: The Women and Infants Transmission Study

article

Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.

artículo científico publicado en 2015

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

artículo científico publicado en 2004

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis

artículo científico publicado en 2004

More on Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China

scientific article published on 08 July 2020

Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life

artículo científico publicado en 2011

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants

artículo científico publicado en 2010

Nevirapine concentrations in newborns receiving an extended prophylactic regimen

artículo científico publicado en 2008

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children

artículo científico publicado en 2012

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

artículo científico publicado en 2016

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

artículo científico publicado en 2000

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

scientific article published on 01 July 2019

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children

artículo científico publicado en 2002

Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration

artículo científico publicado en 2013

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children

artículo científico publicado en 2000

Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection

artículo científico publicado en 2003

Perinatal Exposure to Zidovudine — Benefits and Risks

artículo científico publicado en 2000

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

artículo científico publicado en 2001

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial

artículo científico publicado en 2007

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women

artículo científico publicado en 2006

Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.

artículo científico publicado en 2008

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants

artículo científico publicado en 2011

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

artículo científico publicado en 2004

Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life

artículo científico publicado en 2014

Pharmacokinetics and tolerance of zidovudine in preterm infants

artículo científico publicado en 2003

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

artículo científico publicado en 2018

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women

artículo científico publicado en 2015

Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children

artículo científico publicado en 1999

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

artículo científico publicado en 2001

Pharmacokinetics of oral zidovudine administered during labour: a preliminary study

Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women

artículo científico publicado en 2004

Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women

artículo científico publicado en 2001

Piloting very early infant diagnosis of HIV in Lesotho: Acceptability and feasibility among mothers, health workers and laboratory personnel.

artículo científico publicado en 2018

Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999.

artículo científico publicado en 1999

Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications

artículo científico publicado en 2011

Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission

artículo científico publicado en 2012

Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial

artículo científico publicado en 2011

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy

artículo científico publicado en 2009

Postnatal Human Immunodeficiency Virus-1 Transmission After Cessation of Infant Extended Antiretroviral Prophylaxis and Effect of Maternal Highly Active Antiretroviral Therapy

article

Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants

artículo científico publicado en 2010

Preconception ART and preterm birth: real effect or selection bias? - Authors' reply.

artículo científico publicado en 2017

Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission

artículo científico publicado en 2014

Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose

artículo científico publicado en 2003

Pregnancy and medicines: time for paradigm change

artículo científico publicado en 2022

Preventing Human Immunodeficiency Virus Acquisition in Youth-Generations at Risk

artículo científico publicado en 2017

Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection

artículo científico publicado en 2010

Prevention of Breast Milk Transmission of HIV: The Time Is Now

article

Prevention of Hiv-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in Hiv-1-Infected Women with High Cd4 Cell Count (Impaact Promise): A R

artículo científico publicado en 2017

Prevention of Mother-to-Child HIV-1 Transmission—Why We Still Need a Preventive HIV Immunization Strategy

article

Prevention of Mother-to-Child Transmission of HIV-1

article

Prevention of mother-to-child HIV transmission: can we meet the goal of global elimination of new pediatric infections?

artículo científico publicado en 2013

Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries

artículo científico publicado en 2022

Programmatic impact of the evolution of WHO pediatric antiretroviral treatment guidelines for resource-limited countries (Tukula Fenna Project, Uganda).

artículo científico publicado en 2012

Progress in prevention of perinatal HIV‐1 ⬇️

artículo científico publicado el 1 de junio de 1997

Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief

artículo científico

Progression of HIV Disease Among Women Following Delivery

article

Prophylactic Immune Globulin in Children with HIV Disease

article

Prophylactic Intravenous Immunoglobulin in HIV-Infected Children With CD4+ Counts of 0.20×109/L or More

artículo científico publicado en 1992

Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglo

artículo científico publicado en 1992

Protecting the Next Generation — Eliminating Perinatal HIV-1 Infection

article

Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission

artículo científico publicado en 2017

Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Cli

artículo científico publicado en 2000

RIFABUTIN

scientific article published on 01 January 1998

Raltegravir pharmacokinetics in neonates following maternal dosing

artículo científico publicado en 2014

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.

artículo científico publicado en 2017

Realization of an AIDS-free generation: ensuring sustainable treatment for children

artículo científico publicado en 2014

Recent progress in immune-based interventions to prevent HIV-1 transmission to children

artículo científico publicado en 2017

Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States

artículo científico publicado en 2007

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression

artículo científico publicado en 2015

Reply to Kojima and Klausner.

artículo científico publicado en 2018

Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA

artículo científico publicado en 2003

Risk factors for in utero and intrapartum transmission of HIV.

artículo científico publicado en 2005

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

artículo científico publicado en 1999

Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team

artículo científico publicado en 2000

Risk of HIV Acquisition During Pregnancy and Postpartum: A Call for Action

artículo científico publicado en 2018

SARS-COV-2 Maternal-Child Transmission: Can It Occur Before Delivery and How Do We Prove It?

artículo científico publicado en 2020

SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis

artículo científico publicado en 2022

Safety Data Timelines for Pregnant Individuals With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy

artículo científico publicado en 2024

Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children

artículo científico publicado en 2002

Safety and effectiveness of efavirenz versus nevirapine-based regimens in resource-limited settings: evidence, clinical practice and modelling projections

artículo científico publicado en 2012

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

artículo científico publicado en 1997

Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.

artículo científico publicado en 2005

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months

artículo científico publicado en 2003

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

artículo científico publicado en 2001

Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis

artículo científico publicado en 2017

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants

artículo científico publicado en 2002

Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis

artículo científico publicado en 2014

Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts

artículo científico publicado en 2010

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis

artículo científico publicado en 2011

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

artículo científico publicado en 2014

Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants

artículo científico publicado en 2014

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

artículo científico publicado en 2012

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

artículo científico publicado en 2019

Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic

artículo científico publicado en 2021

Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinica

artículo científico publicado en 1999

Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group

artículo científico publicado en 1999

Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis

artículo científico publicado en 2022

Short-course zidovudine for prevention of perinatal infection

artículo científico publicado en 1999

Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group

artículo científico publicado en 1995

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants

artículo científico publicado en 2012

Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection

artículo científico publicado en 2002

Strengthening the Evidence: Similar Rates of Neural Tube Defects Among Deliveries Regardless of Maternal HIV Status and Dolutegravir Exposure in Hospital Birth Surveillance in Eswatini

artículo científico publicado en 2023

Successes and Challenges in the Perinatal HIV-1 Epidemic in the United States as Illustrated by the HIV-1 Serosurvey of Childbearing Women

article

Summary of the Workshop on Passive Immunotherapy in the Prevention and Treatment of HIV Infection

article

Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework

artículo científico publicado en 2022

Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study

artículo científico publicado en 2015

Tale of two epidemics--the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus

artículo científico publicado en 2003

Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.

artículo científico publicado en 2016

Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding

artículo científico publicado en 2016

Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection

scientific article published on May 2013

The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration

artículo científico publicado en 2021

The Impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316

article

The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know?

article

The challenges of success: adolescents with perinatal HIV infection

artículo científico publicado en 2013

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

artículo científico publicado en 2018

The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps

scientific article published on 01 September 2020

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

artículo científico publicado en 1997

The role of antiretroviral therapy in the management of HIV infection in women.

artículo científico publicado en 1996

Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

article

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection

artículo científico publicado en 2012

Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.

artículo científico publicado en 2018

Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis

artículo científico publicado en 2016

Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.

artículo científico publicado en 2008

Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel

artículo científico publicado en 2015

Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group

artículo científico publicado en 1999

Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America

artículo científico publicado en 2004

Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America

scientific article published on 01 February 2005

Treatment interruption after pregnancy: effects on disease progression and laboratory findings

artículo científico publicado en 2009

Tuberculosis in pediatric antiretroviral therapy programs in low- and middle-income countries: Diagnosis and screening practices

artículo científico publicado en 2014

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

artículo científico publicado en 2002

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States

artículo científico publicado en 2002

Unresolved antiretroviral treatment management issues in HIV-infected children

artículo científico publicado en 2012

Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels

scientific article published on 01 December 2019

Use of Ritonavir-Boosted Nirmatrelvir in Pregnancy

artículo científico publicado en 2022

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

artículo científico publicado en 2000

Using Observational Data to Inform HIV Policy Change for Children and Youth

article

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

artículo científico publicado en 1997

Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value

artículo científico publicado en 2010

What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

artículo científico publicado en 2022

World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries

artículo científico publicado en 2012

Youth engagement in developing an implementation science research agenda on adolescent HIV testing and care linkages in sub-Saharan Africa

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda